The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of CuriosityStream Inc (NASDAQ: CURI) was $6.31 for the day, up 0.16% from the previous closing price of $6.30. In other words, the price has increased by $0.16 from its previous closing price. On the day, 0.65 million shares were traded. CURI stock price reached its highest trading level at $6.64 during the session, while it also had its lowest trading level at $6.22.
Ratios:
Our analysis of CURI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.50. For the most recent quarter (mrq), Quick Ratio is recorded 1.87 and its Current Ratio is at 1.87. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On September 17, 2021, JP Morgan started tracking the stock assigning a Overweight rating and target price of $15.JP Morgan initiated its Overweight rating on September 17, 2021, with a $15 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 09 ’25 when Hayden Phillip Brady sold 1,000 shares for $4.89 per share. The transaction valued at 4,891 led to the insider holds 90,052 shares of the business.
Hayden Phillip Brady bought 2,000 shares of CURI for $3,340 on Dec 12 ’24. The Chief Financial Officer now owns 38,000 shares after completing the transaction at $1.67 per share. On Dec 13 ’24, another insider, Hayden Phillip Brady, who serves as the Chief Financial Officer of the company, bought 1,000 shares for $1.69 each. As a result, the insider paid 1,690 and bolstered with 25,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CURI now has a Market Capitalization of 362257728 and an Enterprise Value of 334361984. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.63 while its Price-to-Book (P/B) ratio in mrq is 6.18. Its current Enterprise Value per Revenue stands at 6.166 whereas that against EBITDA is 40.294.
Stock Price History:
The Beta on a monthly basis for CURI is 1.81, which has changed by 5.009524 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, CURI has reached a high of $6.37, while it has fallen to a 52-week low of $0.98. The 50-Day Moving Average of the stock is 83.84%, while the 200-Day Moving Average is calculated to be 174.44%.
Shares Statistics:
CURI traded an average of 537.59K shares per day over the past three months and 1883370 shares per day over the past ten days. A total of 56.93M shares are outstanding, with a floating share count of 29.54M. Insiders hold about 48.12% of the company’s shares, while institutions hold 12.87% stake in the company. Shares short for CURI as of 1745971200 were 364522 with a Short Ratio of 0.68, compared to 1743379200 on 311630. Therefore, it implies a Short% of Shares Outstanding of 364522 and a Short% of Float of 1.1199999999999999.
Dividends & Splits
With its trailing 12-month dividend rate of 0.12, CURI has a forward annual dividend rate of 0.09. Against a Trailing Annual Dividend Yield of 0.019047618
